Form 8-K, current report

Coherus Oncology, Inc., 8-K filed 2026-08-17

Published 17 Aug 2026 · retrieved 18 Aug 2026, 02:30 EDT · version 1Official source

The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.

Filing record

1

8-K filed with the Securities and Exchange Commission by Coherus Oncology, Inc. (CIK 0001512762) on 2026-08-17.

2

Accession number 0001104659-26-097949. EDGAR reports the filing package as 1 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/0001104659-26-097949-index.htm.

Items reported on the cover

1

Item 1.01: Entry into a Material Definitive Agreement

2

Item 1.02: Termination of a Material Definitive Agreement

3

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

4

Item 9.01: Financial Statements and Exhibits